Table of Contents DECLARATION ..................................................................................................................................... i APPROVAL ........................................................................................................................................... ii ACKNOWLEDGEMENT ..................................................................................................................... iii DEDICATION ....................................................................................................................................... iv LIST OF TABLES .................................................................................................................................vii LIST OF FIGURES .............................................................................................................................. viii LIST OF ABBREVIATIONS .................................................................................................................ix ABSTRACT ............................................................................................................................................ x CHAPTER ONE:  INTRODUCTION .................................................................................................... 1 1.0 Introduction ................................................................................................................................... 1 1.1 Problem statement ......................................................................................................................... 2 1.2 Objectives of the study .................................................................................................................. 3 1.2.1 General objective ....................................................................................................................... 3 1.2.2 Specific objective ....................................................................................................................... 3 1.3 Research questions ........................................................................................................................ 3 1.4 Justification of the study ............................................................................................................... 4 1.5: Study scope .................................................................................................................................. 4 1.5.1: Geographical scope ................................................................................................................... 4 1.5.2: Content scope ............................................................................................................................ 4 1.5.3: Time scope ................................................................................................................................ 4 CHAPTER TWO: LITERATURE REVIEW ......................................................................................... 5 2.1 Overview of Family planning ....................................................................................................... 5 2.2 Contraception among people living with HIV/AIDS .................................................................... 5 2.3 Determinants of family planning use ............................................................................................ 6 CHAPTER THREE: METHODOLOGY ............................................................................................... 8 3.1 Study design .................................................................................................................................. 8 3.2 Study area ...................................................................................................................................... 8 3.3 Study population ........................................................................................................................... 8 3.3.1. Inclusion criteria ....................................................................................................................... 8 3.3.2. Exclusion criteria ...................................................................................................................... 8 3.4. Sample size determination ........................................................................................................... 8 3.5 Sampling technique ....................................................................................................................... 8 3.6. Data collection methods ............................................................................................................... 8

vi

3.7. Data Processing and analysis ....................................................................................................... 9 3.8 Quality control .............................................................................................................................. 9 3.9. Ethical considerations .................................................................................................................. 9 3.10 Study Limitations ........................................................................................................................ 9 CHAPTER FOUR: RESULTS ............................................................................................................. 10 4.1 Sociodemographic characteristics of the respondents ................................................................. 10 4.2 Contraceptive use of any method ................................................................................................ 11 4.3 Contraceptive methods used ....................................................................................................... 12 4.4 Prevalence of LAPMs ................................................................................................................. 13 4.5 Chi square analysis of associated factors for LAPMs ................................................................. 14 CHAPTER FIVE: DISCUSSION AND CONCLUSION..................................................................... 15 5.1 Discussion ................................................................................................................................... 15 5.1.1 Prevalence of LAPMs use ........................................................................................................ 15 5.1.2 Factors influencing use of LAPMs .......................................................................................... 15 5.2 Conclusion and recommendations .............................................................................................. 16 APPENDICES ...................................................................................................................................... 21 Appendix i: Consent form ................................................................................................................. 21 Appendix ii: Questionnaire ............................................................................................................... 22 Appendix v: Map of Uganda showing location of Bushenyi district ................................................ 24 Appendix vi: map of Bushenyi district showing location of KIUTH ............................................... 25

ABSTRACT

 Unintended pregnancy remains an alarming global public health concern with its subsequent socioeconomic impact on individuals, families, and the society. Moreover, preventing unintended pregnancy among women living with HIV is essential to decrease pregnancyrelated morbidity and mortality as well as mother to child HIV transmission. Thus, the purpose of this study was to identify the level of use of long acting and permanent contraceptive methods (LAPMs) among HIV positive women attending Kampala international university teaching hospital and factors that may influence the use of such contraceptive methods. An institution-based cross-sectional study design was used. A pretested questionnaire was used to collect data from 60 respondents. Data was then entered into IBM SPSS version 25 for analysis. Results were then presented in tables and charts.The mean age of the respondents was 28.3 years ±4.9 (Std) and the majority (90%) of the participants had 1-3 children while 80% were married. Prevalence of LAMPs was 31.7%. Factors associated with use of LAPMs were; age ≥35 years (X2=22.24; P=